|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Interest and other income (expense), net | ||
| Change in fair value of SAFE liability | ||
| Total other expense, net | ||
| Net loss | ||
| Weighted common shares outstanding (in Shares) | ||
| Basic and diluted net loss per share (in Dollars per share) | ||
| Net loss per share, basic | ||
| Net loss per share, diluted | ||
| Weighted-average number of common shares used in computing net loss per share, basic | ||
| Weighted-average number of common shares used in computing net loss per share, diluted | ||
| Unrealized loss on available-for-sale securities | ||
| Comprehensive loss |
Loading...
